Granta Park, Cambridge

MedImmune at Granta Park – success to which other companies aspire

When Cambridge Antibody Technology (CAT) took the lease of a single 20,000 sq ft laboratory building at Granta Park in 2001 no-one could have foreseen that eight years later, transformed into MedImmune, they would employ 400 staff and occupy three buildings with a total floor area of over 180,000 sq ft of laboratory and office buildings, reflecting the nine-fold growth.

"Cambridge, and Granta Park in particular, has proven to be the very best place we could have chosen for our UK hub.  The access to an increadible pool of specialist skills, the east connectivity with London and the vibrant, creative science community has all contributed greatly to our success here.  Granta park is a big part of that success and continues to dmonstrate howlocating our operation in a well designed, well run science park can help us attract and retain the very best scientists and staff."
Dr Jane Osborn, MedImmune Site Leader and Vice President Research

PPD at Granta Park - develop your business as business develops

PPD moved to Granta Park in 2002 when it took 28,500 sq ft. The first expansion, called "PPD Phase II," was completed in 2005 and added a further 22,000 sq ft.

Phase III, which completes in 2009, adds an additional 40,000 sq ft. Once complete, PPD will occupy some 90,000 sq ft at Granta Park, creating a PPD 'campus'.

"With demand growing for our drug development services, now is the right time to expand to enable us to continue to meet our clients' needs.  Over the years, we have developed a good working relationship with the Granta Park team, and we have been very pleased with the design and development process."
Chris Neild, Vice President of Finance, PPD